Page results
-
From 10 September 2025, proxies will be able to see more information in your MyCare account. Proxies are individuals such as parents or carers who have access to your MyCare account.
-
This page has been written for patients who are having radiotherapy or proton beam therapy to the oesophagus.
-
General urology is now reopen to GP referrals. Should you wish to refer to LUTS or benign prostate services at UCLH, you can do so via the e-referrals service.
-
Contact the Patient Advice and Liaison Service (PALS)
-
GP queries and contact form
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
This page is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
-
This page has been written for patients who are receiving radiotherapy to the chest for a tumour of the lung, oesophagus, or lymphoma.
-
Communication to clinicians using the biochemistry laboratory service provided by HSL. From 14 April 2025 zinc analyses on blood samples will be changed to state of the art Inductively Coupled Mass Spectrometry (ICP-MS).
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
File results
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0341 - Senior staff contact details
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care